Filing Flows › Kestra Medical Technologies (KMTS) › Q4 FY26 › vs Q3 FY26
Kestra Medical Technologies (KMTS) Q4 FY26 vs Q3 FY26 (quarter over quarter)
Kestra Medical Technologies's revenue rose $4.1M (+17%) from $24.6M in Q3 FY26 to $28.6M in Q4 FY26.
Kestra Medical Technologies, Q4 FY26: revenue $28.6M (+66% year over year), operating margin -137.4%, net loss $38.8M, operating cash flow −$18.7M. The chart draws each line against Q3 FY26, the increases inside each band.
Every line
| Line | Q4 FY26 | Q3 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $28.6M | $24.6M | $4.1M | +17% |
| Other income, net | $701K | $634K | $67K | +11% |
| Net loss | $38.8M | $34.2M | $4.7M | +14% |
| Costs & expenses | $68.2M | $59.4M | $8.8M | +15% |
| Operating costs | $68.0M | $59.3M | $8.7M | +15% |
| Income tax | $192K | $35K | $157K | +449% |
| Cost of revenue | $13.0M | $11.6M | $1.3M | +11% |
| Research & development | $5.6M | $5.0M | $662K | +13% |
| SG&A | $49.4M | $42.7M | $6.7M | +16% |
| Operating cash sources | $38.8M | $34.2M | $4.7M | +14% |
| Depreciation | $2.3M | $2.0M | $342K | +17% |
| Share-based compensation | $10.3M | $10.1M | $196K | +2% |
| Working capital & other | $7.5M | $3.7M | $3.8M | +102% |
| Cash used in operations | $18.7M | $18.4M | $354K | +2% |
| Net loss absorbed | $38.8M | $34.2M | $4.7M | +14% |
Questions
How much did Kestra Medical Technologies's revenue grow quarter over quarter in Q4 FY26?
Kestra Medical Technologies's revenue rose $4.1M (+17%) from $24.6M in Q3 FY26 to $28.6M in Q4 FY26.